IL6 and cancer: The most plausible hypothesis is that the leak may trigger an immunosuppressive response that promotes disease recurrence in two ways: First, the inflammatory response to the leakage could elevate levels of mediators like tumor necrosis factor α, interleukin 1β, and interleukin 6, which may encourage proliferation, cell motility, invasiveness, and survival of circulating cancer cells [42].